Saturday 17 October 2026 Export ACHC’s income statement to Excel — free account

Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 63.6%, free cash flow grew 856.5% and total debt rose 6.49%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

29.98 1.06 −3.41%

Follow ACHC

Alert me

Market cap: $2.9B
P/E: 0.0×
Fwd P/E: 21.1×
Dividend yield: —
F-score: 5/9
Altman Z: 0.92
Beneish M: −3.58
Dividend safety: 2/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 4.14%

Capital & Financial Ratios $m

Market Cap 2,890.00

Revenue 3,367.67

Net Income (1,122.20)

Free Cash Flow (100.31)

Net Debt 2,243.28

Current Ratio 1.57

Debt/Equity 1.22

P/E ratio 0.00

Fwd P/E 21.10

P/S ratio 0.81

P/B ratio 1.38

Past 5Y EPS Growth —

This Y EPS Growth (23.69%)

Next Y EPS Growth 20.99%

Next Y revenue growth 3.48%

Next 5Y EPS Growth 2.82%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 13.60%

10-year low 10-year high

P/B against its own 10 years 44.23%

10-year low 10-year high

EV/Sales against its own 10 years 13.56%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	100	76	133	171
Receivables	361	365	441	471
Inventory	—	—	—	—
Other	134	136	240	203
	596	577	814	845

	2023	2024	2025	Q'26
Payables	156	233	150	135
ST’ Debt	29	77	28	33
Other	—	—	—	—
	886	578	525	538

Compound Annual Growth %

	10y	5y	3y
Sales	6.32%	9.65%	8.27%
Cash Flow	(5.83%)	(27.51%)	(29.76%)
Earnings	0.00%	0.00%	0.00%
Book Value	1.48%	0.52%	(11.51%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	829	866	—	—	—
’25	771	869	852	821	3,313
’24	768	796	816	774	3,154
’23	704	731	750	743	2,929
’22	617	652	667	675	2,610
’21	551	582	588	593	2,314
’20	509	491	548	541	2,090

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	62	162	—	—	—
’25	11	134	73	(86)	132
’24	(321)	171	163	117	130
’23	44	164	138	116	462
’22	77	149	41	114	381
’21	76	90	110	98	374
’20	46	219	207	187	659

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1	134	—	—	—
’25	(163)	(18)	(57)	(179)	(416)
’24	(455)	18	(27)	(87)	(550)
’23	(22)	73	10	6	68
’22	28	68	(35)	31	91
’21	17	37	67	11	133
’20	(13)	164	153	130	434

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.05	0.12	—	—	—
’25	0.09	0.33	0.40	(13.02)	(12.16)
’24	0.83	0.85	0.74	0.35	2.78
’23	0.72	0.79	(2.39)	0.63	(0.24)
’22	0.67	0.88	0.78	0.67	2.98
’21	0.11	0.49	0.73	0.77	2.10
’20	0.38	0.46	0.42	(8.78)	(7.59)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	32.54	26.92	24.27	25.13	11.09	48.62	50.07	66.49	36.50	12.63	Analyst estimates 2026–2028 Powerpack
	High	65.89	54.34	45.35	35.40	50.99	68.65	89.85	86.37	87.77	47.08
People
People	Employees	40,400	40,600	42,100	42,800	42,200	22,500	23,000	23,500	25,500	25,000
	Revenue/emp, $m	0.07	0.07	0.05	0.05	0.05	0.10	0.11	0.12	0.12	0.13
Income, $m
Income, $m	Revenue	2,811	2,836	1,905	2,008	2,090	2,314	2,610	2,929	3,154	3,313
	Gross margin, %	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
	EBT	33	237	67	78	184	276	374	(25)	342	(1,066)
	EBT margin, %	1.17	8.35	3.54	3.90	8.79	11.91	14.33	(0.87)	10.84	(32.18)
	Net income	4	200	(175)	110	(669)	196	280	(16)	264	(1,092)
	Depreciation	145	153	91	100	108	111	121	136	154	194
Per share, $
Per share, $	Revenue	32.80	32.62	21.82	22.92	23.78	26.07	29.11	32.20	34.42	36.52
	Earnings	0.07	2.30	(2.01)	1.24	(7.65)	2.15	3.05	(0.24)	2.79	(12.16)
	Cash flow	4.22	4.60	4.74	3.80	7.50	4.22	4.24	5.08	1.42	1.45
	Capex	(4.06)	(3.57)	(3.11)	(2.52)	(2.56)	(2.72)	(3.22)	(4.34)	(7.42)	(6.04)
	Free cash flow	0.15	1.03	1.63	1.28	4.94	1.50	1.02	0.74	(6.01)	(4.59)
	Book value	25.29	29.59	26.73	28.60	21.62	28.36	31.36	30.59	33.55	21.49
	Shares, m	86	87	87	88	88	89	90	91	92	91
Valuation, ×
Valuation, ×	P/E	411.13	14.76	0.00	26.58	0.00	28.36	26.80	0.00	14.16	0.00
	P/S	1.00	1.04	1.18	1.45	2.12	2.33	2.80	2.43	1.15	0.39
	P/B	1.30	1.14	0.96	1.16	2.33	2.14	2.60	2.56	1.18	0.66
	EV/Sales	2.15	2.16	2.83	2.97	3.43	2.92	3.29	2.86	1.75	1.10
	EV/FCF	456.60	68.22	37.80	53.22	16.51	50.70	93.94	124.05	(10.02)	(8.78)
Cash, $m
Cash, $m	Operating cash flow	361	400	414	333	659	374	381	462	130	132
	Capex	(348)	(310)	(272)	(221)	(225)	(241)	(289)	(395)	(680)	(548)
	Free cash flow	13	90	143	112	434	133	91	68	(550)	(416)
Balance, $m
Balance, $m	Working capital	85	94	34	79	1,215	90	118	(290)	0	289
	Total debt	3,288	3,240	3,193	3,149	3,122	1,497	1,386	1,372	1,957	2,500
	Net debt	3,231	3,173	3,143	3,050	2,744	1,363	1,288	1,272	1,881	2,367
	Shareholders’ equity	2,168	2,573	2,333	2,505	1,899	2,517	2,813	2,782	3,074	1,949
Returns, %
Returns, %	ROA	0.12	3.21	(2.79)	1.67	(10.05)	3.38	5.60	(0.42)	4.52	(19.20)
	ROIC	5.15	4.76	3.49	3.53	4.92	6.67	7.13	7.91	6.59	5.62
	ROE	0.32	8.43	(7.16)	4.50	(30.52)	8.63	10.25	(0.77)	8.73	(43.91)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
NHC National HealthCare Corporation	$3.9B	26.9×	8.4×	+8.83% (above 0%: growing)	+68.63% (above 0%: growing)	−41.57% (below 0%: shrinking)	100.00%	11.99%	Compare
ACHC Acadia Healthcare Company, Inc.	$2.9B	— (loss-making)	21.1×	−0.39% (below 0%: shrinking)	−63.64% (below 0%: shrinking)	+856.54% (above 0%: growing)	100.00%	10.14%
AVAH Aveanna Healthcare Holdings Inc.	$2.8B	9.5×	10.4×	+13.73% (above 0%: growing)	+46.15% (above 0%: growing)	+57.89% (above 0%: growing)	32.59%	11.93%	Compare
GRDN Guardian Pharmacy Services, Inc.	$2.5B	37.5×	39.5×	+2.16% (above 0%: growing)	+133.33% (above 0%: growing)	+60.83% (above 0%: growing)	22.75%	5.87%	Compare
BKD Brookdale Senior Living Inc.	$2.4B	— (loss-making)	— (loss-making)	−11.61% (below 0%: shrinking)	n/m	+533.14% (above 0%: growing)	29.94%	11.86%	Compare
MD Pediatrix Medical Group, Inc.	$2.3B	13.1×	11.3×	+4.04% (above 0%: growing)	+6.52% (above 0%: growing)	−6.56% (below 0%: shrinking)	27.16%	11.67%	Compare
ADUS Addus HomeCare Corporation	$2.2B	20.4×	14.9×	+8.01% (above 0%: growing)	+24.17% (above 0%: growing)	+81.74% (above 0%: growing)	32.21%	10.32%	Compare
SGRY Surgery Partners, Inc.	$1.9B	— (loss-making)	— (loss-making)	+2.75% (above 0%: growing)	n/m	−60.63% (below 0%: shrinking)	22.41%	12.78%	Compare
ASTH Astrana Health, Inc.	$1.9B	44.3×	29.7×	+48.52% (above 0%: growing)	+110.53% (above 0%: growing)	−67.74% (below 0%: shrinking)	10.70%	3.53%	Compare
Median of peers	$2.3B	23.6×	13.1×	+6.03%	+57.39%	+25.67%	28.55%	11.77%

All 55 Medical Care Facilities stocks →

Acadia Healthcare Company, Inc. (ACHC) key facts

Concern: Acadia Healthcare Company, Inc. reported a net loss of $1.1 billion, or a loss of $12.16 per share, for fiscal 2025.
Strength: Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024.
Acadia Healthcare Company, Inc. (ACHC) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, ACHC traded at $29.98, a market capitalization of $2.9 billion.
Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 0.8× sales.
Return on equity was −43.9% and debt-to-equity 1.22.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 0.92 (distress zone) for fiscal 2025.